Search

Search Constraints

You searched for: Author/Creator Califano, Catello

Search Results

1. Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial. (18th May 2021)

2. Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon. Issue 5 (May 2015)

3. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. Issue 1 (19th September 2022)

4. Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. (20th November 2012)

5. Efficacy and safety of new direct antiviral agents in hepatitis C virus–infected patients with diffuse large B‐cell non‐Hodgkin's lymphoma. Issue 1 (24th November 2017)

6. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials. Issue 4 (1st June 2022)

7. Feasibility and efficacy of dose‐dense and dose‐intense ABVD for high‐risk patients with advanced Hodgkin lymphoma. (14th April 2015)

9. Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study). (19th April 2018)

10. Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. Issue 12 (2nd December 2018)